Skip to main content

INNOVATE Corp.

corporate_fare Company Profile

INNOVATE Corp.

VATE·NYSE·Manufacturing·CIK 0001006837

INNOVATE Corp. is a diversified holding company with a portfolio of subsidiaries across various operating segments. As of December 31, 2025, the company's three reportable segments are Infrastructure, Life Sciences, and Spectrum, along with an Other segment for businesses not meeting separate reporting thresholds. The Infrastructure segment includes DBM Global Inc. (DBMG), a group of companies providing fully integrated structural and steel construction services. The Life Sciences segment, Pansend Life Sciences, LLC (Pansend), focuses on supporting healthcare and biotechnology product development. The Spectrum segment, HC2 Broadcasting Holdings Inc. and its subsidiaries (Broadcasting), operates Over-The-Air (OTA) broadcasting stations across the United States, including Puerto Rico. The Other segment comprises all other businesses or investments that do not individually or collectively meet the definition of a segment. Due to new milestone covenants in certain debt agreements from refinancing transactions completed during the third quarter of 2025, INNOVATE is required to begin a sales process for its Infrastructure and Spectrum segments.

INNOVATE Corp. (NYSE:VATE) is a publicly traded company in the Manufacturing sector. Wiseek has independently scored 23 items for VATE at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • INNOVATE's Q4 Revenue Soars 61.7%, Net Loss Significantly Narrows
  • INNOVATE's MediBeacon Subsidiary Receives Top Medical Journal Recognition for Kidney Function System
  • INNOVATE Corp. to Receive $4.6 Million Cash Dividend from Subsidiary DBM Global

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.25B
Net Income
-$60.6M
Diluted EPS
-$4.84
Op. Cash Flow
$146.6M
Free Cash Flow
$146.1M
Gross Profit
$199.7M
Operating Income
$28.7M
Cash & Equivalents
$112.1M
Total Debt
$581.4M
Debt / Equity
-2.42×
Net Margin
-4.9%
Shares Outstanding
13.66M sh
Source: 10-K · filed 2026-03-26 · accession 0001006837-26-000014
$7.16
52-week range · as of 2026-09-03 $3.75 – $21.3
Market cap
$97.68M
Volume
99.3K (0.1× avg)
3-mo avg 706.7K
Live data · 2026-09-14 05:40 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed VATE - Filings & News (Page 2)

VATE
Mar 26, 2026, 4:17 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $4.03
Real-time Price: $7.16 info
Change: +$3.13 (+78%) info
Market Cap: $97.676M info
VATE
Feb 10, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.42
Real-time Price: $7.16 info
Change: +$1.74 (+32%) info
Market Cap: $97.676M info
VATE
Feb 02, 2026, 8:32 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.63
Real-time Price: $7.16 info
Change: +$1.53 (+27%) info
Market Cap: $97.676M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets